ArticleRSC advances2025
Differentiation properties of 3D scaffolds nanostructured with multi-walled carbon nanotubes on human induced pluripotent stem cells.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Implementation of stem cell therapy using novel nanotechnologies is a fruitful approach for regenerative medicine. Induced pluripotent stem cells (iPSC) are considered a gold standard for stem cells research for personalized regenerative medicine, especially for tissues with low regenerative capabilities. To overcome some limitations of existing systems, a novel microporous, self-standing, elastomeric 3D scaffold of polydimethylsiloxane with micrometric cavities of tunable sizes, nanostructured with multi-walled carbon nanotubes (MWCNTs) was developed to investigate its biocompatibility and differentiation potential towards iPSC. Four types of 3D MWCNTs scaffolds were selected to study the role of scaffolds pore size (small: 100-250 µm; large: 250-600 µm) and the level of MWCNTs nanostructuration (3% w/w and 6% w/w) in their effects on iPSC. All scaffolds appeared highly biocompatible with iPSC for up to 7 days, but 3D MWCNTs scaffolds with large pore size (250-600 µm) allowed the most adequate environment for cell growth, increasing cell mass in absence of proliferation stimuli. Only at this porosity, regardless of MWCNTs amount, the iPSC gene expression profile was characterized by a distinct pattern, compatible with a reduced pluripotency and a mesoderm-like differentiation. These results might support possible application of these scaffolds in regenerative medicine, opening new scenarios for stem cell-based approaches.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.